about cholesterol
Update:
cholesterol: Action mechanism
The Benzoate cholesterol is a skin protector.
file dci vidal
= I fogli vidali DCI costituiscono una base di conoscenza farmacologica e terapeutica, proposta agli operatori sanitari, oltre ai documenti normativi pubblicati.
= cholesterol benzoate 1 % (10 mg/g) + zinc oxidide 5 % (50 mg/g) ointment
Last modification: 17/11/2023 - Revision: 17/11/2023
| ATC |
|---|
D - Madicaments dermatologies D02 - EMOLLIENTS ET PROTECTEURS D02A - Emollients and protectors D02AB - Medicaments based on zinc |
| Risk on pregnancy and breastfeeding | dopant | Vigilance | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||||||||||||||||||||||||||
Insacticsazioni et modalités D'amministration Cholesterolo Benzoato 1 % + Oxyde 5 % POMIndications
Ce médicament est indiqué dans les cas suivants :
- irritative dermitity, extra treatment (de la)
dosaggio = socket application
= Administration- Voie cutanée
dosaggio Patient from 1 month- Patient whatever the weight
- DERMITY IMPROVATIVE, APOIRT TREATION (DE LA)
- Dosaggio standard
- 1 Application 2 to 3 times Day
Indications
Ce médicament est indiqué dans les cas suivants :
- irritative dermitity, extra treatment (de la)
dosaggio = socket application
= Administration- Voie cutanée
dosaggio Patient from 1 month- Patient whatever the weight
- DERMITY IMPROVATIVE, APOIRT TREATION (DE LA)
- Dosaggio standard
- 1 Application 2 to 3 times Day
= socket application
= Administration- Voie cutanée
dosaggio Patient from 1 month- Patient whatever the weight
- DERMITY IMPROVATIVE, APOIRT TREATION (DE LA)
- Dosaggio standard
- 1 Application 2 to 3 times Day
- Voie cutanée
dosaggio Patient from 1 month- Patient whatever the weight
- DERMITY IMPROVATIVE, APOIRT TREATION (DE LA)
- Dosaggio standard
- 1 Application 2 to 3 times Day
Patient from 1 month
- Patient whatever the weight
- DERMITY IMPROVATIVE, APOIRT TREATION (DE LA)
- Dosaggio standard
- 1 Application 2 to 3 times Day
Information relating to patient safety cholesterol benzoate 1 % + zinc oxidide 5 % POM Risk level: x Critique III Haut II moderate i low
Contraindicazioni x Critique= gravity: Contre-indication absolue - Dermatose infected at the point of application
- Dermatosis suining at the point of application
- hypersensitivity to one of the components
Precautions || ModeratoII Modéré level of gravity: precautions
Drug interactions Refer to the paragraph of drug interactions Product
Pregnancy and breastfeeding
Contacts and precautions for use pregnancy (month) = allattamento al seno 1 2 3 4 5 6 | || 407 7 8 9 Rischi II II II= Precauction
| Risk level: | x Critique | III Haut | II moderate | i low |
|---|
Contraindicazioni x Critique= gravity: Contre-indication absolue - Dermatose infected at the point of application
- Dermatosis suining at the point of application
- hypersensitivity to one of the components
x Critique
= gravity: Contre-indication absolue - Dermatose infected at the point of application
- Dermatosis suining at the point of application
- hypersensitivity to one of the components
|
Precautions || ModeratoII Modéré level of gravity: precautions
II Modéré
level of gravity: precautions
Drug interactions Refer to the paragraph of drug interactions Product
Refer to the paragraph of drug interactions Product
Pregnancy and breastfeeding
| Contacts and precautions for use | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||||||||||||||||||||||||
See also substances
zinc oxidide
chemistry
| Iupac | zn o |
|---|
